Literature DB >> 9749723

Schwann cells genetically modified to secrete human BDNF promote enhanced axonal regrowth across transected adult rat spinal cord.

P Menei1, C Montero-Menei, S R Whittemore, R P Bunge, M B Bunge.   

Abstract

The infusion of BDNF and NT-3 into Schwann cell (SC) grafts promotes regeneration of brainstem neurones into the grafts placed in adult rat spinal cord transected at T8 (Xu et al., 1995b). Here, we compared normal SCs with SCs genetically modified to secrete human BDNF, grafted as trails 5 mm long in the cord distal to a transection site and also deposited in the transection site, for their ability to stimulate supraspinal axonal regeneration beyond the injury. SCs were infected with the replication-deficient retroviral vector pL(hBDNF)RNL encoding the human preproBDNF cDNA. The amounts of BDNF secreted (as detected by ELISA) were 23 and 5 ng/24 h per 106 cells for infected and normal SCs, respectively. Biological activity of the secreted BDNF was confirmed by retinal ganglion cell bioassay. The adult rat spinal cord was transected at T8. The use of Hoechst prelabelled SCs demonstrated that trails were maintained for a month. In controls, no SCs were grafted. One month after grafting, axons were present in SC trails. More 5-HT-positive and some DbetaH-positive fibres were observed in the infected vs. normal SC trails. When Fast Blue was injected 5 mm below the transection site (at the end of the trail), as many as 135 retrogradely labelled neurones could be found in the brainstem, mostly in the reticular and raphe nuclei (normal SCs, up to 22, mostly in vestibular nuclei). Numerous neurones were labelled in the ventral hypothalamus (normal SCs, 0). Also, following Fast Blue injection, a mean of 138 labelled cells was present in dorsal root ganglia (normal SCs, 46) and spinal cord (39 vs. 32) rostral to the transection. No labelled spinal neurones rostral to the transection were seen when SCs were not transplanted. Thus, the transplantation of SCs secreting increased amounts of BDNF improved the regenerative response across a transection site in the thoracic cord. Moreover, the enhanced regeneration observed with infected SCs may be specific as the largest response was from neurones known to express trkB.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9749723     DOI: 10.1046/j.1460-9568.1998.00071.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  54 in total

1.  Selective innervation of retinorecipient brainstem nuclei by retinal ganglion cell axons regenerating through peripheral nerve grafts in adult rats.

Authors:  M Avilés-Trigueros; Y Sauvé; R D Lund; M Vidal-Sanz
Journal:  J Neurosci       Date:  2000-01-01       Impact factor: 6.167

Review 2.  Neurotrophic factors, cellular bridges and gene therapy for spinal cord injury.

Authors:  L L Jones; M Oudega; M B Bunge; M H Tuszynski
Journal:  J Physiol       Date:  2001-05-15       Impact factor: 5.182

3.  A cell type-specific allele of the POU gene Oct-6 reveals Schwann cell autonomous function in nerve development and regeneration.

Authors:  Merhnaz Ghazvini; Wim Mandemakers; Martine Jaegle; Marko Piirsoo; Siska Driegen; Manousos Koutsourakis; Xsander Smit; Frank Grosveld; Dies Meijer
Journal:  EMBO J       Date:  2002-09-02       Impact factor: 11.598

4.  Dissociated predegenerated peripheral nerve transplants for spinal cord injury repair: a comprehensive assessment of their effects on regeneration and functional recovery compared to Schwann cell transplants.

Authors:  Caitlin E Hill; Danika M Brodak; Mary Bartlett Bunge
Journal:  J Neurotrauma       Date:  2012-08-10       Impact factor: 5.269

5.  The effect of a spinal cord hemisection on changes in nitric oxide synthase pools in the site of injury and in regions located far away from the injured site.

Authors:  Nadezda Lukácová; Mária Kolesárová; Karolína Kuchárová; Jaroslav Pavel; Dalibor Kolesár; Jozef Radonák; Martin Marsala; Malgorzata Chalimoniuk; Jozef Langfort; Jozef Marsala
Journal:  Cell Mol Neurobiol       Date:  2006-06-20       Impact factor: 5.046

6.  A transgenic mouse model engineered to investigate human brain-derived neurotrophic factor in vivo.

Authors:  Fabrice Guillemot; Italina Cerutti; Charles Auffray; Marie-Dominique Devignes
Journal:  Transgenic Res       Date:  2007-01-16       Impact factor: 2.788

Review 7.  Gene therapy approaches to enhancing plasticity and regeneration after spinal cord injury.

Authors:  Steffen Franz; Norbert Weidner; Armin Blesch
Journal:  Exp Neurol       Date:  2011-01-31       Impact factor: 5.330

Review 8.  Recent therapeutic strategies for spinal cord injury treatment: possible role of stem cells.

Authors:  D Garbossa; M Boido; M Fontanella; C Fronda; A Ducati; A Vercelli
Journal:  Neurosurg Rev       Date:  2012-04-27       Impact factor: 3.042

Review 9.  Multipotent skin-derived precursors: adult neural crest-related precursors with therapeutic potential.

Authors:  Karl J L Fernandes; Jean G Toma; Freda D Miller
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-01-12       Impact factor: 6.237

10.  Transduced Schwann cells promote axon growth and myelination after spinal cord injury.

Authors:  Kevin L Golden; Damien D Pearse; Bas Blits; Maneesh S Garg; Martin Oudega; Patrick M Wood; Mary Bartlett Bunge
Journal:  Exp Neurol       Date:  2007-07-13       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.